Patients with Parkinson's disease (PD) and essential tremor (ET) have a higher risk of cognitive impairment than age-matched controls. Only a few small studies (11-18 subjects per group) have directly compared the cognitive profile of these conditions. Our aim was to compare the cognitive profile of patients with these two conditions to each other and to healthy individuals in a population-based study of non-demented participants.
| INTRODUCTION
Patients with Parkinson's disease (PD) and essential tremor (ET) have a higher risk of cognitive impairment than healthy individuals who are matched by age and education. 1, 2 Their pattern of dysfunction has traditionally been labeled as that of a fronto-subcortical type. 3 Deficits in areas such as attention, 4, 5 verbal fluency, 2, 5 and memory 6 may be noted even at early stages of both conditions. 2, 7 In PD, this impairment has been linked with degeneration of cortical association areas. 8 In ET, the neuropathological correlates of cognitive impairment have not been completely elucidated. 9 While considerable efforts are being made to fully characterize and better understand the non-motor features of ET and PD, the two most common tremor disorders, [10] [11] [12] only three studies have directly compared the cognitive profile of these two disorders, and each of these had small sample sizes (11-18 patients in each group). 6, 13, 14 Furthermore, two of the studies 6, 13 enrolled surgical patients, a highly selected group whose cognitive deficits are likely to differ from (ie, be less marked than) those of the average patient. All three studies assessed patients who self-selected for treatment (ie, patients attending clinics) rather than those sampled directly from the population. Clinic patients often differ phenotypically from those in the population. Finally, patients with both ET and PD may have Alzheimer's disease (AD) and other forms of dementia, and none of the studies explicitly removed these from the sample to obtain a less-confounded and cleaner picture of cognition.
Hence, there is a need for more comprehensive study.
In this population-based study of non-demented participants, we performed a head-to-head comparison of the cognitive profile of 180 individuals with ET and 46 with PD, comparing them to 2212 healthy aged controls. Our four a priori hypotheses were that (i) both conditions affect cognitive performance relative to that of controls, even in the absence of a clinical diagnosis of dementia, (ii) a continuum exists in this performance from normal controls to ET to PD (most severe), (iii) the deficits in ET and PD are in many of the same cognitive domains;
however, (iv) the affected cognitive domains do not overlap completely, and there are demonstrable differences between ET and PD.
| MATERIAL AND METHODS

| Study population
This investigation was part of the Neurologic Disorders in Central Spain (NEDICES), a population-based survey of the prevalence, incidence, and determinants of major elderly-associated conditions.
Detailed accounts of the background, study population, and methods of the survey have been reported.
15-17
| Standard protocol approvals, registrations, and patient consents
All procedures were approved by the ethical standards committees on human experimentation at "12 de Octubre" Hospital (Madrid). Written (signed) informed consent was obtained from all enrollees.
| Study evaluation
Detailed accounts of the study assessments have been published. 16, 18, 19 Face-to-face evaluations were performed at baseline (1994) (1995) and at one follow-up (1997) (1998) 
| Diagnostic criteria for PD and ET
Diagnostic criteria for ET, 18 PD, 19 and dementia 1 have been described
elsewhere. For the diagnosis of PD, the study questionnaire had three questions to screen for parkinsonism (ie, previous diagnosis of PD, presence of tremor, and presence of bradykinesia). Persons who screened positive (ie, they responded positively to ≥1 of these three questions) for PD underwent a general neurological examination and the motor portion of the UPDRS. 20 Parkinsonism was diagnosed when at least two cardinal signs (resting tremor, rigidity, bradykinesia, and impaired gait/postural reflexes) were present. PD was diagnosed in patients without secondary causes of parkinsonism or atypical features. 19 A Hoehn and Yahr stage was assigned to each case. 21 The evaluation of tremor and diagnosis of ET involved a screening question in the questionnaire ("have you ever had tremor of the head, hands, or legs that has lasted longer than several days?") with 68.6% sensitivity. 22 The same examination as in PD was performed.
It also included an assessment of postural and kinetic tremors (sustained bilateral arm extension, bilateral finger-nose-finger maneuver, drawing Archimedes spirals) and UPDRS. 20 Participants were diagnosed with ET if they had an action tremor of the head, limbs, or voice without any other recognizable cause. Second, the tremor had to be of gradual onset (ie, slow and progressive) and (i) present for at least 1 year or (ii) accompanied by a family history of the same disorder (at least one reportedly affected first-degree relative). In addition, on an Archimedes spiral, tremor severity had to be moderate or greater (rating >2 according to the Washington Heights-Inwood Genetic Study of ET Rating Scale). 23 Participants with tremor related to alcohol withdrawal, hyperthyroidism, anxiety, PD, antidopaminergic drug intake, lithium therapy, or other known causes of tremor were not considered to have ET. If ET was diagnosed, the age of onset of tremor was elicited. 
| Neuropsychological tests
During the follow-up evaluation (1997-1998), all participants underwent a short neuropsychological evaluation. 24, 25 The tests used were as follows: 
| Final selection of participants
Of the 5278 participants who were enrolled at baseline, 672 were lost to follow-up (112 declined and 560 were unreachable) and 790 died before they were contacted the second time. Of the remaining 3816, we excluded 921 with missing neuropsychological information and 457 subjects with stroke or dementia. The final sample (N=2438) included patients with PD (N=46) and ET (N=180), as well as the remaining healthy controls (N=2212) ( Figure 1 
| Statistical analyses
Statistical analyses where performed using R. 33 Significance was accepted at the 5% level (two-sided the performance of the ET and PD groups in the different cognitive domains avoiding for the confounding effects of age and education.
The cutoff for normality was defined as one (T score<40) or two standard (T score<30) deviations from the reference values. 34 To further adjust for confounding, a series of nonparametric stratified analyses was performed. The purpose of these tests was to understand the magnitude and directionality of the effect of these confounders on the cognitive tests results rather than their significance (ie, if PD or ET scored lower than the controls across the different strata). The strata were defined by age in tertiles (≤68 years; from 69 to 74 years and ≥75 years), gender (male vs female), education (illiterate, can write and read, primary studies, secondary studies, or higher), presence of depressive symptoms (no vs yes), and medications with CNS effects (no vs yes). In addition, we double-checked the results of the stratified results in the younger and more educated subjects. We performed a final subanalysis to define the influence of the age of onset (≥65 years) on the cognitive performance of the patients with ET. The purpose was to evaluate whether there was a different cognitive phenotype of those with an older onset. 35 
| RESULTS
| Demographic features
The final sample included 46 patients with PD, 180 patients with ET, and 2212 healthy controls ( 
| Cognitive performance-ET and PD vs controls (hypothesis 1)
Essential tremor and Parkinson's disease patients performed significantly more poorly than controls in several tests and in global cognition (Table 2 ; Fig. S1 ). When the patients with PD and ET were compared with the controls, the mean raw difference for the global cognition test (ie, the MMSE-37) was −2.3 points and −1.6 points,
respectively. The six-object and the story delayed recall test scores were −0.7 and −0.8 points significantly worse in the patients with PD than the controls. In the verbal fluency tasks, there was a greater than one-point difference for both the animal-and fruit-naming tests between the PD group and the controls. Finally, the patients with ET erred one point more than the controls in the cognitive processing speed task, the Trail Making Test part A, although the significance was lost in the post hoc comparison. In analyses that stratified by age in tertiles, gender, prior education, presence of depressive symptoms, and CNS drug intake, the group differences observed in the primary analyses persisted (data not shown).
| Cognitive performance-trend analyses (hypothesis 2)
Based on the Jonckheere-Terpstra test ( relationships continued in stratified analyses that considered the same variables as in hypothesis 1 (data not shown).
| Cognitive profile-ET vs PD (hypotheses 3 and 4)
The head-to-head comparison of the ET and PD patients is detailed in Table 3 . The calculated T scores were consistently lower in the patients with PD, except for the cognitive processing speed task, but they only reached significance in the lower number of animals that the PD individuals named (P=.05 The other domains' differences remained similar and did not reach significance.
| Age of tremor onset and its influence on the cognitive performance of ET
When we stratified patients with ET by age of tremor onset, 58 (32.2%) had their onset prior to age 65 years and 122 (67.8%) had an onset ≥65 years. The two groups differed in terms of their median current age (71.5 vs 75.5 years, respectively; P<.05). Their neuropsychological performance was similar in all tests, with only the one exception of the animalnaming task (P<.05). When we computed the adjusted T scores by age and educational attainment, this difference was no longer significant (P=.10).
| DISCUSSION
In this study, we characterized the cognitive performance of a population-based sample of 46 patients with PD, 180 patients with ET, and 2212 healthy controls. Our goal was to test four a priori hypotheses about the cognitive profile of PD and ET patients relative to that of controls and relative to one another.
Our first a priori hypothesis was that both ET and PD would have Our second a priori hypothesis was that a gradient of neuropsychological performance would exist between PD, ET, and healthy con- showing broader deficits. 13 A more recent study of surgical patients by Benge et al., 14 which validated an executive scale in a sample of deep brain stimulation candidates, included 15 patients with PD and 11 patients with ET. The patients with PD performed more poorly that the patients with ET in this scale. 14 Most prior studies enrolled and assessed patients with PD or patients with ET, but not both. None of these studies were population-based or specifically ruled out AD and other dementia subtypes.
The third and fourth hypotheses suggested an overlap of the affected cognitive domains in ET and PD, yet not a complete overlap. In the study of Lombardi et al., the ET group performed more poorly in verbal fluency tests, whereas the patients with PD also had poorer performance in visuospatial, memory, and attentional tasks. 6 Moreover, Gasparini et al. reported an altered performance in some attentional tasks for both ET and PD, but with the patients with PD performing less well in some verbal fluency and executive tasks. 13 In our cohort, in the trend analyses, the PD participants performed less well than the patients with ET, and both groups performed less well than the controls, in tests measuring global cognition, memory, and verbal fluency. These results confirm the existence of an overlap of affected domains. 36 Nonetheless, when the intensity and the percentage of subjects with an impaired function in a specific domain were compared, the two groups showed differences. In this headto-head comparison, patients with ET consistently scored less well than the patients with PD in cognitive processing speed, although this result was marginally significant in the trend analyses. This fact could be related to greater cerebellar involvement of the ET cases 37, 38 as, in our opinion, tremor itself could not justify an increased number of errors. 38 Nonetheless, this last point will have to be confirmed in future studies, as it is fairly hypothetical. On the other hand, our results differ from those of Lombardi et al 6 as the PD, and not the ET, had a significantly poorer performance in verbal fluency. This is
in agreement with what Gasparini et al. 13 and larger epidemiological studies. 39 Overall, the differences noted for some of the tests were modest when compared with previous studies. 39 The largest difference was noted for the six-object test in the patients with PD and patients with ET. dementia, can impact the quality of life, predict "loss of independence,"
and impair activities of daily living in these frequent movement disorders. [43] [44] [45] [46] Nonetheless, the clinical and prognostic implications of these deficits will have to be studied further.
Recently, it has been proposed that late onset of tremor (ie, ≥65 years) could represent a different clinical entity than earlier onset ET. 35 With this in mind, we performed a subanalysis, stratifying patients with ET by age of onset. The neuropsychological performance of the two groups was similar in all tests. Based on our data, there does not seem to be a distinct cognitive phenotype in participants with younger tremor onset (ie, <65 years) compared with later tremor onset (ie, ≥65 years); however, additional studies are needed before firm conclusions may be reached.
Our study has several limitations. First, we had to exclude a large proportion of subjects because of lost to follow-up, missing neuropsychological data, and other attrition issues. The excluded subjects were slightly older and had a slightly higher percentage of illiterates than those who were included. The potential bias introduced would most likely have been toward a poorer performance among those who were excluded. In addition, the NEDICES study only included participants aged 65 years or older. Therefore, these analyses will have to be replicated in younger subjects. Second, the number of tests we could include was limited because the evaluation was part of a larger epidemiological study. It would have been interesting to characterize additional domains (eg, visuospatial function). Another important limitation of our study is the lack of additional time-point evaluations, from which the evolution of these cognitive phenotypes could have been addressed.
Certainly, future efforts should include additional follow-up visits to confirm and expand our results. Moreover, our evaluation of depression was limited, and we may have underascertained depression, resulting in residual confounding. Nevertheless, a validation study showed a high level of agreement between the data generated from the screening question we used and a more detailed in-person psychiatric assessment, suggesting that such residual confounding is likely to have been low. 47 Further, we could not completely rule out confounding effects of other covariates. Because of the non-normality of the neuropsychological data, our approach to minimize the effect of these confounders in the tests' scores was to perform stratified analyses, evaluate T scores adjusted by age and education, and also reproduce some of the analyses in younger subjects with a higher educational category.
We believe that our conclusions are important for the definition and characterization of the cognitive aspects of ET and PD. We have confirmed that PD and ET impair cognitive performance, even in the absence of dementia, and that a continuum of severity exists between the two conditions, with PD showing a greater impact than ET. Also, there is some overlap in the type of impairment that they produce, but with disease-specific features, such as the predominant effect in verbal fluency of PD and in cognitive processing speed of ET. The last aspect should be further investigated to elucidate the mechanisms and structural correlates producing these diverse early cognitive effects. Besides their pathophysiological implications, these data could have added value in the differential diagnosis, prognosis, and management of these frequent movement disorders.
